IBA Annual Conference Toronto 2025
2 Nov - 7 Nov 2025
Session information
Committee(s)
Antitrust Section
(Lead)
Description
With more vigorous enforcement at least in some parts of the world, what are the considerations for disclosing cartel conduct to regulators and filing for leniency? Are the increase of leniency programmes across the world and the proliferation of private damages actions in many jurisdictions affecting the cost-benefit analysis when deciding to file for leniency? What are regulators doing to uncover cartels ex officio (whistleblowing, active monitoring including using software tools) and are they pushing the boundaries of what constitutes cartel conduct such as indirect information exchange?